Tim Fleischer is Chairman of TransVoyant Inc., a cloud-based real-time analytics software company with a market-leading Supply Chain Intelligence Platform. He is also the founder and Chairman of PD Power Systems LLC, a systems integrator, designer, and manufacturer of expeditionary power generation and distribution systems for the U.S. military, and Chairman of PD Systems, a provider of technology-enhanced logistics, maintenance, and training services.
Tim previously served as President of Washington operations for Engineered Support Systems, Inc. [NASDAQ: EASI], a diversified manufacturer of integrated military electronics and support equipment, and logistics service provider to the U.S. Department of Defense and foreign militaries.
From 1994 to 2002, Tim was President and CEO of Radian, Inc., a full-service engineering, logistics and systems integration firm acquired by Engineered Support Systems, Inc. (ESSI) in May 2002. Upon Radian’s acquisition, he was elected to ESSI’s Board of Directors and named group president with responsibility for the operational and financial performance of four wholly owned subsidiaries.
Tim also founded Radian Systems in 1994, a commercial software firm that was acquired by Sequoia Software Corporation [NASDAQ: SQSW] in 1999.
Tim received a Bachelor of Science degree from the U.S. Naval Academy, where he graduated in 1981 with a commission in the U.S. Navy. He also holds a Master of Science degree in Information Systems from The George Washington University. He served on active duty as a Naval Surface Warfare Officer from 1981-1987, followed by eight years at the Pentagon in the active reserves. Tim was a member of the Board of Directors of the National Defense Industrial Association (NDIA) from 2001-2020.
CEO & PRESIDENT, TRANSVOYANT
Dennis Groseclose is the founder and CEO of TransVoyant, a company driving autonomic supply chains for its customers. These self-aware supply chains act on their own to orchestrate, regulate, and optimize business functions, decisions, and customer service across complex global value chains. His leadership experience spans senior roles at Fortune 100 companies, founding and building successful companies from scratch through IPO, and as an Officer in the U.S. Air Force and a member of the U.S. Senior Executive Service.
Dennis previously served at Lockheed Martin, delivering three international public private partnership (PPP) training programs with revenue of $11+ Billion. He led the line of business that created, developed, and delivered post-9/11 risk-based, real-time intelligence programs for the United States and FVEY National Security Organizations. These programs still provide continuous security across global transportation, logistics and critical infrastructure while ensuring the free flow of commerce. After meeting the homeland security challenge, he led an operating company to create and deliver long-term public-private partnerships for turnkey pilot training with Australia, Singapore, and the United Kingdom.
Earlier in his career, Dennis was on the leadership team of a technology startup, C-bridge Internet Solutions. He led solution development and customer delivery from initial angel investment, through multiple rounds of funding, resulting in a successful IPO. He began his career in the United States Air Force as a Program Director for national intelligence and space systems programs.
Dennis is a graduate of the U.S. Air Force Academy, earned his MBA from Louisiana State University and his MS from the Air Force Institute of Technology. He has previously served on the Board of Directors for McLane Advance Technologies, the National Center for Simulation, the Center for Applied Identity Management Research, and the Economic Crime Institute. Dennis is the author of 8 U.S. and International patents.
MANAGING PARTNER, p74 VENTURES
Jeremy Sohn is the Managing Partner of P74 Ventures, a venture fund focused on platform technologies that have the potential to transform the core business & operations of Pharma. Jeremy is a venture investor, serial entrepreneur, and pharma executive responsible for leading pharma business model innovation and transformation. Prior to launching P74 Ventures, Jeremy was VP, Global Head of Digital BD&L, Partnerships, & Innovation at Novartis where he oversaw three teams: (i) a pharma-tech and digital health venture investment fund (operating as dRx Capital), (ii) a digital BD&L partnership and transactions team, and (iii) the Novartis Biome, a10,000+ internal innovation community and accelerator.
Prior to Novartis, Jeremy was Managing Director at MPM Capital where he led their pharma-tech fund and founded and invested in two companies, CentrosHealth (merged with Clinical Ink and acquired by GI Partners) and TriNetX (acquired by Carlyle Group). In 2011, Jeremy co-founded GrapeVine, a social networking and big-data analytics company. From 2007-2011, Jeremy was COO and VP, Strategy & Corporate Development for North Plains Systems, where he led the company’s growth and eventual sale to Accel-KKR. In 2000, he co-founded the first, commercial open-source operating system company, Wasabi Systems. And, most recently, in 2021, Jeremy co-founded Virb, an ed-tech, talent acquisition, and human capital-as-a-service platform designed to support the 300,000+ life science roles created annually.
Joseph B. Volpe III
Managing Director, Global Health Innovation Fund and General Manager Global Health Innovation PE Fund, LLC
As Vice President, Merck Global Health Innovation Group, Managing Director Merck Global Health Fund, and GM Merck Global Health PE Fund (a 500m evergreen fund), Joe has been instrumental in transforming Merck GHIF into a venture capital, growth equity, and M&A leader. Joe was named one of the top 5 rising stars in corporate venture capital in 2016.
Joe has a background in business, and engineering as well as 20+ years in investing. He invests in IT, remote patient monitoring, sensor technology, physician-patient digital health ecosystems, AI, manufacturing, supply chain, and remote care distribution solutions. He is currently leading Manufacturing/Supply Chain, IT, and RWE/D investments and strategies at Merck.
Joe holds board/observer seats on Aerosafe, ClearDATA, Tag-n-Trac, TriNetX, Prognos, Preventice, and TransVoyant. His exits/former boards include Exostar, HealthSense, Humedica, Liaison, Physicians Interactive, Volansi, and Remedy Informatics. He played a key role in the sale of healthcare analytics firm Humedica to UnitedHealth Group, which produced a 17-fold return, and has led and assisted investments and acquisitions at numerous other portfolio companies.
Joe initially got involved as a healthcare investor in 2001, when he joined the Global MarketPlace Innovation unit of Johnson & Johnson. There he explored whitespace growth opportunities and startups on behalf of J&J’s consumer, pharmaceutical, and device sectors. He started his career as a consultant with EDS before spending more than two decades at Johnson & Johnson, where he held innovation and investment roles across Consumer, Pharma, and Device sectors.
Joe has presented at numerous venture-oriented speaker panels, classes, and conferences, including the National Venture Capital Association, Microsoft CIO Summit, HIMSS, MHealth, Health 2.0, Columbia, and Startup Health.